These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 38495892)

  • 1. Interferon lambda in respiratory viral infection: immunomodulatory functions and antiviral effects in epithelium.
    Liu YG; Jin SW; Zhang SS; Xia TJ; Liao YH; Pan RL; Yan MZ; Chang Q
    Front Immunol; 2024; 15():1338096. PubMed ID: 38495892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Cell Profiling of IFN-λ Response Shows pDCs Express Highest Level of IFN-λR1 and Are Directly Responsive via the JAK-STAT Pathway.
    Kelly A; Robinson MW; Roche G; Biron CA; O'Farrelly C; Ryan EJ
    J Interferon Cytokine Res; 2016 Dec; 36(12):671-680. PubMed ID: 27617757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Regulation of Type I and Type III Interferon Signaling.
    Stanifer ML; Pervolaraki K; Boulant S
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30901970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs.
    Zanoni I; Granucci F; Broggi A
    Front Immunol; 2017; 8():1661. PubMed ID: 29234323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudorabies virus-induced expression and antiviral activity of type I or type III interferon depend on the type of infected epithelial cell.
    Yin Y; Ma J; Van Waesberghe C; Devriendt B; Favoreel HW
    Front Immunol; 2022; 13():1016982. PubMed ID: 36405751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enterovirus 2A
    Kastan JP; Tremblay MW; Brown MC; Trimarco JD; Dobrikova EY; Dobrikov MI; Gromeier M
    mBio; 2021 Apr; 12(2):. PubMed ID: 33849973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon induction and function at the mucosal surface.
    Durbin RK; Kotenko SV; Durbin JE
    Immunol Rev; 2013 Sep; 255(1):25-39. PubMed ID: 23947345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of SARS-CoV-2 by type I and type III interferons.
    Felgenhauer U; Schoen A; Gad HH; Hartmann R; Schaubmar AR; Failing K; Drosten C; Weber F
    J Biol Chem; 2020 Oct; 295(41):13958-13964. PubMed ID: 32587093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of Type III Interferon (IFN) Genes
    Peterson ST; Kennedy EA; Brigleb PH; Taylor GM; Urbanek K; Bricker TL; Lee S; Shin H; Dermody TS; Boon ACM; Baldridge MT
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpesviruses and the Type III Interferon System.
    Yin Y; Favoreel HW
    Virol Sin; 2021 Aug; 36(4):577-587. PubMed ID: 33400088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of small molecule activators of the janus kinase/signal transducer and activator of transcription pathway using a cell-based screen.
    Tai ZF; Zhang GL; Wang F
    Biol Pharm Bull; 2012; 35(1):65-71. PubMed ID: 22223339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
    Liu B; Chen S; Guan Y; Chen L
    PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic Heterodimers of Type III Interferon Receptors Require TYK2 for STAT Activation.
    Mesev EV; Guare EG; Ploss A; Toettcher JE
    J Interferon Cytokine Res; 2023 Sep; 43(9):414-426. PubMed ID: 37725008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the IFN-α JAK/STAT Pathway by MERS-CoV and SARS-CoV-1 Proteins in Human Epithelial Cells.
    Zhang Y; Gargan S; Roche FM; Frieman M; Stevenson NJ
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOIL1 Is Essential for the Induction of Type I and III Interferons by MDA5 and Regulates Persistent Murine Norovirus Infection.
    MacDuff DA; Baldridge MT; Qaqish AM; Nice TJ; Darbandi AD; Hartley VL; Peterson ST; Miner JJ; Iwai K; Virgin HW
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Landscape of IFN-λ: Induction, Inhibition, and Potential Clinical Applications to Treat Respiratory Viral Infections.
    Martínez-Espinoza I; Guerrero-Plata A
    Immunohorizons; 2023 Apr; 7(4):265-272. PubMed ID: 37071039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.
    Ank N; West H; Bartholdy C; Eriksson K; Thomsen AR; Paludan SR
    J Virol; 2006 May; 80(9):4501-9. PubMed ID: 16611910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TLR3/IRF1/Type III IFN Axis Facilitates Antiviral Responses against Enterovirus Infections in the Intestine.
    Su R; Shereen MA; Zeng X; Liang Y; Li W; Ruan Z; Li Y; Liu W; Liu Y; Wu K; Luo Z; Wu J
    mBio; 2020 Nov; 11(6):. PubMed ID: 33203755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium.
    Villenave R; Broadbent L; Douglas I; Lyons JD; Coyle PV; Teng MN; Tripp RA; Heaney LG; Shields MD; Power UF
    J Virol; 2015 Dec; 89(24):12309-18. PubMed ID: 26423940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.